Inventor · disambiguated record
Ola Winqvist
Also filed as: WINQVIST OLA
29 granted patents·17 pending applications·273 citations·filing 1997–2023
96Inventor score
Files withISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL14TLA TARGETED IMMUNOTHERAPIES AB8WINQVIST OLA7CARRYGENES BIOENGINEERING LLC4SCRIPPS RESEARCH INST3
Top patents by PatentIndex Score
46 records- 0193US8211425B2Method for treating disseminated cancerWINQVIST OLA·Filed 2006·Granted Jul 3, 2012·27 cites·24 claims
- 0293US6355479B1MHC class II antigen-presenting systems and methods for activating CD4+ T cellsSCRIPPS RESEARCH INST·Filed 1997·Granted Mar 12, 2002·98 cites·36 claims
- 0392US8211424B2Method for treating malignant melanomaWINQVIST OLA·Filed 2006·Granted Jul 3, 2012·26 cites·23 claims
- 0492US8206702B2Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with cancerWINQVIST OLA·Filed 2006·Granted Jun 26, 2012·31 cites·19 claims
- 0592US7951365B2Method for expansion of tumour-reactive T-lymphocytes for immunotherapy of patients with specific cancer typesDEIFIERA FALUN AB·Filed 2008·Granted May 31, 2011·31 cites·31 claims
- 0691US10429385B2Treating conditions associated with sepsisTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Oct 1, 2019·3 cites·8 claims
- 0791US10401357B2Treating cancerTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Sep 3, 2019·3 cites·12 claims
- 0883US8101173B2Method for treating urinary bladder cancerWINQVIST OLA·Filed 2006·Granted Jan 24, 2012·5 cites·16 claims
- 0983US8007785B2Method for treating colon cancer with tumour-reactive T-lymphocytesSENTOCLONE INTERNAT AB·Filed 2006·Granted Aug 30, 2011·27 cites·21 claims
- 1082US9726666B2Diagnosing and treating inflammatory diseasesTLA TARGETED IMMUNOTHERAPIES AB·Filed 2013·Granted Aug 8, 2017·2 cites·9 claims
- 1179US8449489B2Method and means for treating inflammatory bowel diseaseTHORN MAGNUS·Filed 2007·Granted May 28, 2013·7 cites·20 claims
- 1278US8877177B2Chemokine containing apheresis column and methods of useWINQVIST OLA·Filed 2009·Granted Nov 4, 2014·3 cites·21 claims
- 1374US2019361020A1Treating respiratory conditionsTLA TARGETED IMMUNOTHERAPIES AB·Filed 2019·Application pending·0 cites
- 1471US8852581B2Treatment of inflammatory bowel diseaseWINQVIST OLA·Filed 2006·Granted Oct 7, 2014·1 cites·13 claims
- 1570US11059846B2Immune stimulating compoundISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Jul 13, 2021·1 cites·10 claims
- 1670US10502736B2Treating multiple sclerosisTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Dec 10, 2019·0 cites·9 claims
- 1770US10451620B2Treating conditions associated with metabolic syndromeTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Oct 22, 2019·0 cites·9 claims
- 1870US10422800B2Treating respiratory conditionsTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Sep 24, 2019·0 cites·8 claims
- 1970US10408832B2Treating mental disordersTLA TARGETED IMMUNOTHERAPIES AB·Filed 2017·Granted Sep 10, 2019·0 cites·7 claims
- 2070US8709404B2Immunotherapy in cancer treatmentWINQVIST OLA·Filed 2003·Granted Apr 29, 2014·5 cites·14 claims
- 2169US2025177526A1Synthetic Chromosome Encoding Two Or More Chimeric Antigen Receptors Binding To Tumor Associated AntigensCARRYGENES BIOENGINEERING LLC·Filed 2022·Application pending·0 cites
- 2269US2025382339A1Safety Kill Switches for Engineered Cells Carrying Synthetic ChromosomesCARRYGENES BIOENGINEERING LLC·Filed 2022·Application pending·0 cites
- 2369US2024390420A1Use Of Growth Factors For T Cell ActivationCARRYGENES BIOENGINEERING LLC·Filed 2022·Application pending·0 cites
- 2469US2025179149A1Use Of Chemokine Receptors In Cellular HomingCARRYGENES BIOENGINEERING LLC·Filed 2022·Application pending·0 cites
- 2568US11059845B2Immune stimulating macrolidesISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Jul 13, 2021·1 cites·19 claims
- 2668US11059844B2Immune stimulating macrolidesISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Jul 13, 2021·1 cites·20 claims
- 2767US2024033320A1Immunorhelin compounds for intracellular infectionsISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2022·Application pending·0 cites
- 2864US7402430B2MHC class II antigen-presenting systems and methods for activating CD4+ T cellsSCRIPPS RESEARCH INST·Filed 2004·Granted Jul 22, 2008·1 cites·11 claims
- 2964US2023118205A1Novel compounds (immunorhelins)ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2022·Application pending·0 cites
- 3061US2025235528A1Vaccine composition comprising an antigen and a tlr3 agonistISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2023·Application pending·0 cites
- 3158US2025186577A1Vaccine composition comprising an antigen and a tlr3 agonistISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2023·Application pending·0 cites
- 3257US11564969B2Immunorhelin compounds for intracellular infectionsISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Jan 31, 2023·0 cites·15 claims
- 3357US7439335B2MHC class II antigen-presenting systems and methods for activating CD4+ T cellsSCRIPPS RESEARCH INST·Filed 2004·Granted Oct 21, 2008·0 cites·22 claims
- 3453US10919927B2Immune stimulating macrolideISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Feb 16, 2021·0 cites·20 claims
- 3553US2010015161A1Composition Comprising In Vitro Expanded T-Lymphocytes and Vessel Formation Inhibitors Suitable in the Treatment of CancerSENTOCLONE AB·Filed 2009·Application pending·0 cites
- 3652US2011230396A1Anti-infective compounds and uses thereofITH IMMUNE THERAPY HOLDINGS AB·Filed 2009·Application pending·0 cites
- 3752US2023321229A1Vaccine comprising an antigen and a tlr2 agonistISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2021·Application pending·0 cites
- 3850US12377141B2Method for the expansion of HPV immunogen specific T-cellsNEOGAP THERAPEUTICS AB·Filed 2019·Granted Aug 5, 2025·0 cites·17 claims
- 3949US2011081649A1Diagnosis, staging and monitoring of inflammatory bowel diseaseISS IMMUNE SYSTEM STIMULATION AB·Filed 2008·Application pending·0 cites
- 4048US11434258B2Compounds (immunorhelins)ISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Sep 6, 2022·0 cites·12 claims
- 4147US2010304398A1novel diagnostic sensor for rapid and reproducible ro52 protein domain detectionMEADOWLAND BUSINESS PARTNERS AB·Filed 2008·Application pending·0 cites
- 4246US2010227415A1Method and means for prediction of systemic lupus erythematosus susceptibilityISS IMMUNE SYSTEM STIMULATION·Filed 2008·Application pending·0 cites
- 4345US2021040134A1Combinations of macrolide compounds and immune checkpoint inhibitorsISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2019·Application pending·0 cites
- 4440US11304990B2Use of known compounds—intracellular infectionsISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Apr 19, 2022·0 cites·20 claims
- 4539US2011129532A1Method and means for treating viral disease, in particular hiv/aidsISR IMMUNE SYSTEM REGULATION AB·Filed 2009·Application pending·0 cites
- 4635US11672842B2Gonadotropin-releasing hormones for use as adjuvant immunotherapeuticsISR IMMUNE SYSTEM REGULATION HOLDING AB PUBL·Filed 2018·Granted Jun 13, 2023·0 cites·18 claims
Join the waitlist — get patent alerts
Get an alert when Ola Winqvist files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →